188 related articles for article (PubMed ID: 21631396)
41. Andrographolide reduces IL-2 production in T-cells by interfering with NFAT and MAPK activation.
Carretta MD; Alarcón P; Jara E; Solis L; Hancke JL; Concha II; Hidalgo MA; Burgos RA
Eur J Pharmacol; 2009 Jan; 602(2-3):413-21. PubMed ID: 19038244
[TBL] [Abstract][Full Text] [Related]
42. The Nrf2 activator, tBHQ, differentially affects early events following stimulation of Jurkat cells.
Zagorski JW; Turley AE; Dover HE; VanDenBerg KR; Compton JR; Rockwell CE
Toxicol Sci; 2013 Nov; 136(1):63-71. PubMed ID: 23945499
[TBL] [Abstract][Full Text] [Related]
43. Human regulatory T cells rapidly suppress T cell receptor-induced Ca(2+), NF-κB, and NFAT signaling in conventional T cells.
Schmidt A; Oberle N; Weiss EM; Vobis D; Frischbutter S; Baumgrass R; Falk CS; Haag M; Brügger B; Lin H; Mayr GW; Reichardt P; Gunzer M; Suri-Payer E; Krammer PH
Sci Signal; 2011 Dec; 4(204):ra90. PubMed ID: 22375050
[TBL] [Abstract][Full Text] [Related]
44. Human immunodeficiency virus type 1 Tat increases cooperation between AP-1 and NFAT transcription factors in T cells.
Hidalgo-Estévez AM; González E; Punzón C; Fresno M
J Gen Virol; 2006 Jun; 87(Pt 6):1603-1612. PubMed ID: 16690925
[TBL] [Abstract][Full Text] [Related]
45. Clinorotation differentially inhibits T-lymphocyte transcription factor activation.
Morrow MA
In Vitro Cell Dev Biol Anim; 2006; 42(5-6):153-8. PubMed ID: 16848635
[TBL] [Abstract][Full Text] [Related]
46. Negative regulation of the NFAT1 factor by CD45: implication in HIV-1 long terminal repeat activation.
Barbeau B; Robichaud GA; Fortin JF; Tremblay MJ
J Immunol; 2001 Sep; 167(5):2700-13. PubMed ID: 11509614
[TBL] [Abstract][Full Text] [Related]
47. Activation of nuclear factor of activated T cells by human T-lymphotropic virus type 1 accessory protein p12(I).
Albrecht B; D'Souza CD; Ding W; Tridandapani S; Coggeshall KM; Lairmore MD
J Virol; 2002 Apr; 76(7):3493-501. PubMed ID: 11884573
[TBL] [Abstract][Full Text] [Related]
48. CTLA4 ligation attenuates AP-1, NFAT and NF-kappaB activity in activated T cells.
Fraser JH; Rincón M; McCoy KD; Le Gros G
Eur J Immunol; 1999 Mar; 29(3):838-44. PubMed ID: 10092086
[TBL] [Abstract][Full Text] [Related]
49. Gossypol suppresses mouse T lymphocytes via inhibition of NFκB, NFAT and AP-1 pathways.
Song B; Huang G; Tong C; Li G; Wang Z; Xiong Y; Zhang S; Lu J; Guan S
Immunopharmacol Immunotoxicol; 2013 Oct; 35(5):615-21. PubMed ID: 23981004
[TBL] [Abstract][Full Text] [Related]
50. Divergent effects of dithiocarbamates on AP-1-containing and AP-1-less NFAT sites.
Saccani S; Saccani A; Varesio L; Ghosh P; Young HA; Sica A
Eur J Immunol; 1999 Apr; 29(4):1194-201. PubMed ID: 10229086
[TBL] [Abstract][Full Text] [Related]
51. AM404 inhibits NFAT and NF-κB signaling pathways and impairs migration and invasiveness of neuroblastoma cells.
Caballero FJ; Soler-Torronteras R; Lara-Chica M; García V; Fiebich BL; Muñoz E; Calzado MA
Eur J Pharmacol; 2015 Jan; 746():221-32. PubMed ID: 25460026
[TBL] [Abstract][Full Text] [Related]
52. The immunosuppressor st1959, a 3,5-diaryl-s-triazole derivative, inhibits T cell activation by reducing NFAT nuclear residency.
Lindstedt R; Ruggiero V; D' Alessio V; Manganello S; Petronzelli F; Stasi MA; Vendetti S; Assandri A; Carminati P; De Santis R
Int J Immunopathol Pharmacol; 2009; 22(1):29-42. PubMed ID: 19309550
[TBL] [Abstract][Full Text] [Related]
53. Aromadendrin Inhibits T Cell Activation via Regulation of Calcium Influx and NFAT Activity.
Lee HS; Jeong GS
Molecules; 2020 Oct; 25(19):. PubMed ID: 33050076
[TBL] [Abstract][Full Text] [Related]
54. Repression of T-cell function by thionamides is mediated by inhibition of the activator protein-1/nuclear factor of activated T-cells pathway and is associated with a common structure.
Humar M; Dohrmann H; Stein P; Andriopoulos N; Goebel U; Heimrich B; Roesslein M; Schmidt R; Schwer CI; Hoetzel A; Loop T; Pahl HL; Geiger KK; Pannen BH
Mol Pharmacol; 2007 Dec; 72(6):1647-56. PubMed ID: 17878268
[TBL] [Abstract][Full Text] [Related]
55. Carvedilol, a new antioxidative beta-blocker, blocks in vitro human peripheral blood T cell activation by downregulating NF-kappaB activity.
Yang SP; Ho LJ; Lin YL; Cheng SM; Tsao TP; Chang DM; Hsu YL; Shih CY; Juan TY; Lai JH
Cardiovasc Res; 2003 Sep; 59(3):776-87. PubMed ID: 14499879
[TBL] [Abstract][Full Text] [Related]
56. Activation of both nuclear factor of activated T cells and inhibitor of nuclear factor-kappa B kinase beta-subunit-/nuclear factor-kappa B is critical for cyclooxygenase-2 induction by benzo[a]pyrene in human bronchial epithelial cells.
Ding J; Wu K; Zhang D; Luo W; Li J; Ouyang W; Song L; Huang C
Cancer Sci; 2007 Sep; 98(9):1323-9. PubMed ID: 17640307
[TBL] [Abstract][Full Text] [Related]
57. Dose-Dependent Responses of I3C and DIM on T-Cell Activation in the Human T Lymphocyte Jurkat Cell Line.
Liu M; Yasmeen R; Fukagawa NK; Yu L; Kim YS; Wang TTY
Int J Mol Sci; 2017 Jul; 18(7):. PubMed ID: 28671563
[TBL] [Abstract][Full Text] [Related]
58. Phytocomponent 4-hydroxy-3-methoxycinnamaldehyde ablates T-cell activation by targeting protein kinase C-θ and its downstream pathways.
Akber U; Na BR; Ko YS; Lee HS; Kim HR; Kwon MS; Park ZY; Choi EJ; Han WC; Lee SH; Oh HM; Jun CD
Int Immunopharmacol; 2015 Mar; 25(1):130-40. PubMed ID: 25637768
[TBL] [Abstract][Full Text] [Related]
59. Modulation of both activator protein-1 and nuclear factor-kappa B signal transduction of human T cells by amiodarone.
Cheng SM; Lin WH; Lin CS; Ho LJ; Tsai TN; Wu CH; Lai JH; Yang SP
Exp Biol Med (Maywood); 2015 Jan; 240(1):99-108. PubMed ID: 25073960
[TBL] [Abstract][Full Text] [Related]
60. Cutting edge: Regulatory T cells selectively attenuate, not terminate, T cell signaling by disrupting NF-κB nuclear accumulation in CD4 T cells.
Huang YH; Sojka DK; Fowell DJ
J Immunol; 2012 Feb; 188(3):947-51. PubMed ID: 22227565
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
